BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12855009)

  • 21. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular determinants of nuclear receptor-corepressor interaction.
    Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
    Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nuclear corepressors recognize distinct nuclear receptor complexes.
    Cohen RN; Putney A; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polychlorinated biphenyls suppress thyroid hormone receptor-mediated transcription through a novel mechanism.
    Miyazaki W; Iwasaki T; Takeshita A; Kuroda Y; Koibuchi N
    J Biol Chem; 2004 Apr; 279(18):18195-202. PubMed ID: 14985366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
    Quack M; Carlberg C
    J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
    Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
    Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
    Makowski A; Brzostek S; Cohen RN; Hollenberg AN
    Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.
    Forman BM; Yang CR; Au M; Casanova J; Ghysdael J; Samuels HH
    Mol Endocrinol; 1989 Oct; 3(10):1610-26. PubMed ID: 2558297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors.
    Perlmann T; Umesono K; Rangarajan PN; Forman BM; Evans RM
    Mol Endocrinol; 1996 Aug; 10(8):958-66. PubMed ID: 8843412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand- and DNA-induced dissociation of RXR tetramers.
    Chen ZP; Iyer J; Bourguet W; Held P; Mioskowski C; Lebeau L; Noy N; Chambon P; Gronemeyer H
    J Mol Biol; 1998 Jan; 275(1):55-65. PubMed ID: 9451439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation.
    Whitfield GK; Hsieh JC; Nakajima S; MacDonald PN; Thompson PD; Jurutka PW; Haussler CA; Haussler MR
    Mol Endocrinol; 1995 Sep; 9(9):1166-79. PubMed ID: 7491109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.
    Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ
    Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
    Collingwood TN; Rajanayagam O; Adams M; Wagner R; Cavaillès V; Kalkhoven E; Matthews C; Nystrom E; Stenlof K; Lindstedt G; Tisell L; Fletterick RJ; Parker MG; Chatterjee VK
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):248-53. PubMed ID: 8990194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
    Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
    J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct ligand-dependent and independent modes of thyroid hormone receptor (TR)/PGC-1α interaction.
    Yuan C; Nguyen P; Baxter JD; Webb P
    J Steroid Biochem Mol Biol; 2013 Jan; 133():58-65. PubMed ID: 22974658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the mouse preprothyrotropin-releasing hormone gene by retinoic acid receptor.
    Satoh T; Ishizuka T; Monden T; Shibusawa N; Hashida T; Kishi M; Yamada M; Mori M
    Endocrinology; 1999 Nov; 140(11):5004-13. PubMed ID: 10537125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.